A Journal of Hospital Infection special edition focusses on the cost of HCAI, publishing the results of the Scottish from the Evaluation of Cost of Nosocomial Infection (ECONI) Study.
Continue readinglength of stay
Counting the cost of CPE Mk II
Earlier this year, CMI published our article on the cost of a CPE outbreak in London, which cost 1.1m (Euros) over 10 months. EID have recently published a similar article, reporting a 0.6m (Euro) outbreak of CPE in the Netherlands.
Counting the cost of CPE
CMI have just published an article outlining the whopping cost of our CPE outbreak, costing the hospital group in question around £1m over 10 months. We split the costs into ‘actual expenditure’, which would affect the hospital’s financial bottom line, and ‘opportunity costs’ (such as staff time and missed revenue), which can be quite tricky to account for. The large cost of the outbreak and its management accrued over a short time period make a strong financial case for investment in IPC.
All BSIs are expensive, not just antimicrobial resistant ones
Eurosurveillance have recently published a study from the TIMER group evaluating the impact of antimicrobial resistance on hospital mortality, excess length of stay (LOS), and cost of BSI in European hospitals. The study highlights the high cost of BSIs, especially when antimicrobial resistant.
Counting the cost of HCAI outbreaks
There’s surprisingly little literature published on the cost of HCAI outbreaks. In this context, a useful Dutch study in PLoS ONE counts the cost of 7 HCAI outbreaks.
Reflections on Infection Prevention and Control 